Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux


Standort der Organisation:
Bordeaux, Frankreich

Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern

Go to first page Go to previous page 1 von 2 Go to next page Go to last page
Elhai, M., Boubaya, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre Sancho, J.J.,... Allanore, Y. (2019). Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2018-214816
Combe, C., Mann, J., Goldsmith, D., Dellanna, F., Zaoui, P., London, G.,... Macdonald, K. (2019). Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study. Bmc Nephrology, 20. https://dx.doi.org/10.1186/s12882-019-1251-z
Hilz, M.-J., Arbustini, E., Dagna, L., Gasbarrini, A., Goizet, C., Lacombe, D.,... Burlina, A. (2018). Do we understand the pathophysiology of gastrointestinal symptoms in patients with Fabry disease? (pp. S63-S63).
Hilz, M.-J., Arbustini, E., Dagna, L., Gasbarrini, A., Goizet, C., Lacombe, D.,... Burlina, A. (2018). Non-specific gastrointestinal features: Could it be Fabry disease? Digestive and Liver Disease, 50(5), 429-437. https://dx.doi.org/10.1016/j.dld.2018.02.011
Gabay, C., Fautrel, B., Rech, J., Spertini, F., Feist, E., Koetter, I.,... Schiffrin, E.J. (2018). Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease. Annals of the Rheumatic Diseases, 77(6), 840-847. https://dx.doi.org/10.1136/annrheumdis-2017-212608
Ivanovski, I., Djuric, O., Caraffi, S.G., Santodirocco, D., Pollazzon, M., Rosato, S.,... Garavelli, L. (2018). Phenotype and genotype of 87 patients with Mowat-Wilson syndrome and recommendations for care. Genetics in Medicine, 20(9), 965-975. https://dx.doi.org/10.1038/gim.2017.221
Hilz, M.-J., Arbustini, E., Dagna, L., Gasbarrini, A., Goizet, C., Lacombe, D.,... Burlina, A. (2018). Proposal of a rating scale to recognize Fabry disease in patients with nonspecific gastrointestinal symptoms. (pp. S63-S64).
Elhai, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre-Sancho, J.J., Truchetet, M.-E.,... Allanore, Y. (2018). RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK. (pp. 122-122).
Picone, D.S., Schultz, M.G., Otahal, P., Aakhus, S., Al-Jumaily, A.M., Black, J.A.,... Sharman, J.E. (2017). Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses. Journal of the American College of Cardiology, 70(5), 572-586. https://dx.doi.org/10.1016/j.jacc.2017.05.064
Veronese, N., Sergi, G., Stubbs, B., Bourdel-Marchasson, I., Tessier, D., Sieber, C.,... Manzato, E. (2017). Effect of acetyl-l-carnitine in the treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis. European Geriatric Medicine, 8(2), 117-122. https://dx.doi.org/10.1016/j.eurger.2017.01.002
Dietrich, C.F., Bamber, J., Berzigotti, A., Bota, S., Cantisani, V., Castera, L.,... Thiele, M. (2017). EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall in der Medizin, 38(4), 377-394. https://dx.doi.org/10.1055/s-0043-103955
Jin, Y., Andersen, G., Yorgov, D., Ferrara, T.M., Ben, S., Brownson, K.M.,... Spritz, R.A. (2016). Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nature Genetics, 48(11), 1418-1424. https://dx.doi.org/10.1038/ng.3680
Politei, J.M., Bouhassira, D., Germain, D.P., Goizet, C., Guerrero-Sola, A., Hilz, M.-J.,... Burlina, A. (2016). Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment. Cns Neuroscience & Therapeutics, 22(7), 568-76. https://dx.doi.org/10.1111/cns.12542
Potorac, I., Petrossians, P., Daly, A.F., Alexopoulou, O., Borot, S., Sahnoun-Fathallah, M.,... Beckers, A. (2016). T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly. Endocrine-Related Cancer, 23(11), 871-881. https://dx.doi.org/10.1530/ERC-16-0356
Kramar, A., Negrier, S., Sylvester, R., Joniau, S., Mulders, P., Powles, T.,... Filleron, T. (2015). Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project+. Annals of Oncology, 26(12), 2392-8. https://dx.doi.org/10.1093/annonc/mdv380
Schanze, D., Neubauer, D., Cormier-Daire, V., Delrue, M.-A., Dieux-Coeslier, A., Hasegawa, T.,... Zenker, M. (2014). Deletions in the 3' part of the NFIX gene including a recurrent Alu-mediated deletion of exon 6 and 7 account for previously unexplained cases of Marshall-Smith syndrome. Human Mutation, 35(9), 1092-100. https://dx.doi.org/10.1002/humu.22603
Duran, I., Goebell, P., Papazisis, K., Ravaud, A., Weichhart, T., Antonio Rodriguez-Portal, J., & Budde, K. (2014). Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms. Expert Opinion on Drug Safety, 13(3), 361-72. https://dx.doi.org/10.1517/14740338.2014.888056
Leyvraz, S., Piperno-Neumann, S., Suciu, S., Baurain, J.F., Zdzienicki, M., Testori, A.,... Keilholz, U. (2014). Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Annals of Oncology, 25(3), 742-6. https://dx.doi.org/10.1093/annonc/mdt585
Cursiefen, C., Colin, J., Dana, R., Diaz-Llopis, M., Faraj, L.A., Garcia-Delpech, S.,... Dua, H. (2012). Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. British Journal of Ophthalmology, 96(1), 3-9. https://dx.doi.org/10.1136/bjo.2011.204701

Zuletzt aktualisiert 2016-22-06 um 08:39